Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Intervalo de ano de publicação
1.
Internist (Berl) ; 59(8): 857-860, 2018 08.
Artigo em Alemão | MEDLINE | ID: mdl-29356833

RESUMO

We report on a 25-year-old female patient with Crohn's disease and profound lymphocytopenia while receiving corticosteroids and azathioprine. Discontinuation of azathioprine only resulted in a mild increase in CD4+ T cell numbers; however, therapy with the TNFα inhibitor adalimumab was initiated for a clinical flare and resulted in long-lasting clinical remission and rapid normalization of the lymphocytopenia including the respective lymphocyte subsets. Lymphocytopenia is frequently observed as a side effect of immunosuppressive therapy. This case illustrates that lymphocytopenia may also occur in relation to Crohn's disease activity as an extraintestinal manifestation and may then be efficiently treated by escalation of immunosuppressive therapy.


Assuntos
Adalimumab/uso terapêutico , Corticosteroides/efeitos adversos , Anti-Inflamatórios/uso terapêutico , Azatioprina/efeitos adversos , Doença de Crohn/complicações , Doença de Crohn/tratamento farmacológico , Imunossupressores/efeitos adversos , Linfopenia/tratamento farmacológico , Corticosteroides/uso terapêutico , Adulto , Azatioprina/uso terapêutico , Doença de Crohn/imunologia , Feminino , Humanos , Imunossupressores/uso terapêutico , Linfopenia/etiologia , Resultado do Tratamento , Fator de Necrose Tumoral alfa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA